Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Update entities : Adamis pharmaceuticals corporation save search
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-21 (Crawled : 13:20) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: -13.24%
H: 10.73%
C: 0.55%
update pharmaceuticals financial results
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-15 (Crawled : 21:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 21.43%
H: 0.0%
C: -18.24%
update pharmaceuticals financial results
Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate Update
Published: 2023-05-08 (Crawled : 20:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 2.39%
H: 0.0%
C: -3.85%
conference update pharmaceuticals financial results
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
Published: 2023-03-16 (Crawled : 21:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 4.64%
H: 0.0%
C: -12.97%
year update pharmaceuticals financial results
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update
Published: 2023-03-14 (Crawled : 20:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 1.76%
H: 6.7%
C: -1.97%
pharmaceuticals conference year financial update results
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-14 (Crawled : 21:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 0.0%
H: 29.44%
C: 19.44%
pharmaceuticals financial update results
Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects
Published: 2022-09-21 (Crawled : 12:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: -44.42%
H: 35.14%
C: 29.08%
covid-19 trial positive update phase 2
Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects
Published: 2022-09-12 (Crawled : 22:00) - biospace.com/
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 2.87%
H: 9.68%
C: 6.03%
covid-19 positive update study phase 2
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update
Published: 2022-08-08 (Crawled : 12:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 4.28%
H: 0.0%
C: -3.87%
conference update results
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19Interim DSMB review expected in late September
Published: 2022-07-29 (Crawled : 12:00) - biospace.com/
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 0.94%
H: 4.9%
C: 3.4%
covid-19 treatment expected review update study
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
Published: 2022-07-29 (Crawled : 12:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 0.94%
H: 4.9%
C: 3.4%
covid-19 treatment update study
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.